BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 22.15
-1.10 (-4.73%)
At close: Mar 2, 2026
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 1.53 billion as of March 2, 2026. Its market cap has decreased by -3.53% in one year.
Market Cap
1.53B
Enterprise Value
945.73M
Revenue
226.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.15
Market Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 1.53B, an increase of 26.99%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.46B | -24.66% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.44B |
| Flerie AB | 2.85B |
| Vicore Pharma Holding AB | 2.83B |
| Saniona AB | 2.57B |
| Diamyd Medical AB | 2.04B |
| Egetis Therapeutics AB | 1.81B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |